Name: Shirin Nosratnejad

Country: Iran, Islamic Republic of

Affiliation:

Tehran University of Medical Sciences | TUMS · Department of Economics and Management Sciences for Health.

Email: Send an Email


Address:

Tehran University of Medical Sciences | TUMS · Department of Economics and Management Sciences for Health.

Research Interests:

  • Screening
  • Breast Cancer Screening.

Biography:

  • Shirin Nosratnejad holds a Ph.D. degree in health economics from the Tehran University of Medical Sciences (Tehran, Iran) with over 9 years of experience in management and health economics. 
  • She is currently director of the department of health services management of Tabriz University of Medical Sciences, Assistant Professor, and economics consultant of vice chancellor of health. 
  • She has contributed as a researcher at the Iranian Center of Excellence in Health Services Management, as well as at the Tabriz Health Services Management Research Center. 
  • Her research interests include Economic evaluation and Healthcare financing. 

Research:

  • Factors influencing the inpatients satisfaction in public hospitals: A systematic review.
  • Willingness to Pay for Complementary Health Care Insurance in Iran.
  • Systematic Review of Willingness to Pay for Health Insurance in Low and Middle Income Countries.
  • Factors Influencing Basic and Complementary Health Insurance Purchasing Decisions in Iran: Analysis of Data From a National Survey: Factors on Health Insurance in Iran.
  • The Efficacy of Written Information Intervention in Reduction of Hospital Re-admission Cost in Patients With Heart Failure; A Systematic Review and Meta-Analysis.
  • Cost-effectiveness of Anemia Screening in Vulnerable Groups: A Systematic Review.
  • Willingness to Pay for the Social Health Insurance in Iran.
  • Cost-Effectiveness of Mammography Screening for Breast Cancer in a Low Socioeconomic Group of Iranian Women.
  • Cost Effectiveness of Breast Cancer Screening Using Mammography; a Systematic Review.
  • Systematic Review of studies of the cost effectiveness of breast cancer screening – lessons for low and middle income countries.